期刊文献+

去肾交感神经术在临床治疗中的应用:老概念的新发现 被引量:5

下载PDF
导出
摘要 经皮介入射频消融去肾交感神经术治疗高血压已在欧盟获准应用于临床。该疗法的最初人体研究,即概念验证试验是在中国完成的。笔者作为这一疗法的发明参与者(简称研究组)之一,总结了该治疗方法的起源、生理机制、临床验证以及研发和转化医学过程。
作者 王捷
出处 《中国介入心脏病学杂志》 2014年第5期336-338,共3页 Chinese Journal of Interventional Cardiology
  • 相关文献

二级参考文献10

  • 1Levy D, Larson MG, Vasan RS, et al. The progression from hypertension to congestive heart failure[J]. JAMA, 1996,275 (20): 1557-1662.
  • 2DiBona GF, Kopp UC. Neural control of renal function [J]. Physiol Rev, 1997,77 ( 1 ) : 75-197.
  • 3Asai K, Yang GP, Geng YJ, et al. Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse[J]. J Clin Invest, 1999,104 (5) : 551-558.
  • 4Mancia G, Grassi G, Giannattasio C, et al. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage I J]. Hypertension, 1999,34 (4 Pt 2):724- 728.
  • 5Grassi G, Arenare F, Pieruzzi F, et al. Sympathetic activation in cardiovascular and renal disease[Jl. J Nephrol, 2009,22 (2) : 190-195.
  • 6Smith PA, Graham LN, Mackintosh AF, et al. Relationship between central sympathetic activity and stages of human hypertension[J]. Am J Hypertens, 2004,17(3) :217-222.
  • 7Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: A muhicentre safety and proof-of-principle cohort study [J]. Lancet, 2009,373(9671 ) : 1275-1281.
  • 8Esler MD, Krum H, Sobotka PA, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial [J]. Lancet, 2010,376(9756) : 1903-1909.
  • 9Ruilope LM, Schmieder RE. Left ventricular hypertrophy and clinical outcomes in hypertensive patients[J]. Am J Hypertens, 2008,21 (5) : 500-508.
  • 10Pierdomenico SD, Cuccurullo F. Risk reduction after regression of echocardiographic left ventricular hypertrophy in hypertension : A meta-analysis [ J 1. Am J Hypertens, 2010,23 (8) :876-881.

共引文献84

同被引文献38

  • 1匡燕,江凤林.阻断肾交感神经活性治疗慢性肾脏疾病新进展[J].医学信息(医学与计算机应用),2014,0(6):539-540. 被引量:1
  • 2Parati G,Esler M. The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur Heart J, 2012, 33 : 1058-1066.
  • 3Kirchheim H, Ehmke H, Persson P. Sympathetic modulation of renal hemodynamics, renin release and sodium excretion. Klin Wochenschr, 1989,67 : 858-864.
  • 4Id D, Bertog SC, Wunderlieh N, et al. Catheter-based renal sympathectomy. J Cardiovase Surg(Tofino) ,2010,51:721-739.
  • 5Peterssen M., Friberg P, Eisanhofer G, et al. Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure. Eur Heart J ,2005,26:906-913.
  • 6NeubergGW, Miller AB, O' Connor CM, et al. Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J ,2002,144:31-38.
  • 7Davies JE, Manisty CH, Petraco R, et al. First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study. Int J Cardiol,2013, 162:189-192.
  • 8Sobotka PA, Krum H, Bihm M, et al. The role of renal denervation in the treatment of heart failure. Curr Cardiol Rep, 2012,14:285-292.
  • 9Sobotka PA, Mahfoud F, Schlaich MP, et al. Sympatho-renal axis in chronic disease. Clin Res Cardio1,2011,100 : 1049-1057.
  • 10Souza DR, Mill JG, Cabral AM. Chronic experimental myocardial infarction produces antinatriuresis by a renal nerve-dependent mechanism. Braz J Med Biol Res,2004,37:285-293.

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部